Vale SA

VALE · B3

$12.40+$0.20 (+1.64%)TodayMarket closed ·
Prev close $12.20

About VALE

Vale SA engages in the production and exportation of iron ore, pellets, manganese, and iron alloys. The company is headquartered in Rio De Janeiro, Rio De Janeiro and currently employs 65,805 full-time employees. The firm also produces iron ore pellets, copper, platinum group metals (PGMs), gold, silver and cobalt. Vale is engaged in greenfield mineral exploration in five countries and operates logistics systems in Brazil and other regions in the world, including railroads, maritime terminals and ports, which are integrated with mining operations. In addition, Vale has distribution centers to support the delivery of iron ore worldwide. Vale has numerous subsidiaries, including Vale Logistica Uruguay SA, Vale Holdings BV, Vale Overseas Ltd. The Company’s operations abroad cover approximately 30 countries.

Employees
65,805
Headquarters
Rio de Janeiro, Rio De Janeiro
Listed
Jan 2, 1970
Sector
Materials
Industry
Metals & Mining
Website
vale.com

VALE key statistics

Market cap
245.07B
Price-earnings ratio
25.85
Dividend yield
9.41%
Average volume
34.89M
Volume
25.70M
Open price
$12.25
High today
$12.41
Low today
$12.17
52 Week high
$17.94
52 Week low
$11.40

Vale SA (VALE) at a glance

As of Oct 23, 2026, Vale SA (VALE) shares are priced at $12.40, giving the company a market cap of 245.07B, a price-to-earnings ratio of 25.85 and a dividend yield of 9.41%.

Today the stock has traded between $12.17 and $12.41. The current price is 1.9% above the day's low and 0.1% below its high.

Volume so far is 25.70M shares, below the average of 34.89M shares a day.

Over the past year Vale SA has ranged from $11.40 to $17.94, and now sits 15% of the way up that range.

Vale SA met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $0.32 per share against an estimate of $0.4767.

The average analyst price target is $16.71, 34.8% above the current price, from 12 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

17%of 12 analyst ratings say Buy
  • Buy16.7%
  • Hold83.3%
  • Sell0.0%
Price target · 9 analystsAvg $16.71
Low
$14.62
Now
$12.40
High
$19.66

VALE earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 25.4% on average.

  1. Q3 FY24: reported $0.56 per share against an estimate of $0.4841
  2. Q4 FY24: reported -$0.16 per share against an estimate of $0.4542
  3. Q1 FY25: reported $0.33 per share against an estimate of $0.3751
  4. Q2 FY25: reported $0.50 per share against an estimate of $0.3598
  5. Q3 FY25: reported $0.63 per share against an estimate of $0.5178
  6. Q4 FY25: reported -$0.90 per share against an estimate of $0.6363
  7. Q1 FY26: reported $0.44 per share against an estimate of $0.5307
  8. Q2 FY26: reported $0.32 per share against an estimate of $0.4767

VALE news

  • 'Bolsonaro Leads Lula in Brazil Runoff After First Round Surprise' - Bloomberg

  • Piero Cingari

    Brazilian Stocks Rally 14%, Eye Best Day Since 2020 After Bolsonaro's First-Round Victory

  • Lekha Gupta

    Why Is Vale Stock Trading Higher On Monday?

  • Henry Khederian

    Vale Stock Drops Tuesday: What's Going On?

  • Stjepan Kalinic

    Canada Threatens Trump’s Industrial Achilles' Heel

  • 'Indonesia Hikes Nickel Ore Benchmark Price in Hit to Processors' - Bloomberg

  • Press releasePRNewswire

    China's Rare Earth Dominance and the Strategic Failure of the West

  • Tom Gentile

    5 Earnings Trades for the Next 30 Days

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.